Wall Street analyst estimates for Outset Medical, Inc. (OM): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-09 | $-0.69 | ||
| 2026-08-06 | $-0.80 | $-0.72 | -11.6% |
| 2026-05-07 | $-0.83 | $-0.79 | -5.1% |
| 2026-02-11 | $-0.84 | $-0.67 | -24.7% |
| 2025-11-10 | $-0.69 | $-0.66 | -5.3% |
| 2025-08-06 | $-0.84 | $-0.98 | +14.5% |
| 2025-05-07 | $-3.24 | $-0.94 | -242.9% |
| 2025-02-19 | $-5.55 | $-6.20 | +10.5% |
Valuation Ratios
| Price / Book | 0.59 |
| EV / EBITDA | -2.42 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $15.1M | $49.9M | $102.6M | $115.4M | $130.4M | $113.7M | $119.5M |
| Cost of Revenue | $8.1M | $32.9M | $63.0M | $95.0M | $97.5M | $101.4M | $75.1M | $72.7M |
| Gross Profit | -$6.1M | -$17.8M | -$13.0M | $7.6M | $17.8M | $29.0M | $38.6M | $46.8M |
| Research & Development | $22.9M | $23.3M | $28.9M | $36.7M | $48.9M | $57.3M | $38.4M | $21.2M |
| Selling, General & Admin | $17.5M | $29.2M | $75.6M | $101.4M | $130.0M | $141.5M | $113.5M | $92.2M |
| Operating Expenses | $40.4M | $52.5M | $104.4M | $138.1M | $178.9M | $198.8M | $151.9M | $113.5M |
| Operating Income | -$46.6M | -$70.3M | -$117.5M | -$130.5M | -$161.0M | -$169.8M | -$113.4M | -$66.7M |
| EBITDA | -$43.6M | -$62.1M | -$114.8M | -$124.9M | -$152.8M | -$153.8M | -$102.1M | -$62.4M |
| Interest Expense | $4.6M | $4.3M | $2.9M | $1.7M | $3.6M | $12.7M | $23.9M | $14.0M |
| Pre-tax Income | -$49.8M | -$68.3M | -$121.5M | -$131.7M | -$162.7M | -$172.3M | -$127.5M | -$80.9M |
| Income Tax | $25000 | $20000 | 0 | $199000 | $295000 | $523000 | $491000 | $718000 |
| Net Income | -$49.8M | -$68.3M | -$121.5M | -$131.9M | -$163.0M | -$172.8M | -$128.0M | -$81.7M |
| EPS | $-1.65 | $-1.61 | $-2.83 | $-43.41 | $-50.75 | $-52.27 | $-36.95 | $-5.37 |
| EPS (Diluted) | $-1.65 | $-34.06 | $-2.83 | $-43.41 | $-50.75 | $-52.27 | $-36.95 | $-5.37 |
| Shares Outstanding (Diluted) | $2.0M | $2.0M | $2.8M | $3.0M | $3.2M | $3.3M | $3.5M | $15.2M |
Price
| Price | $3.12 |
| Market Cap | $58M |
| Exchange | NASDAQ |
| Country | US |
Related companies: CATX · HSDT · INGN · NNOX · OMI · QTRX · SI
Explore sector: Healthcare · Medical - Devices
More sections of OM: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks